Prior consultations will be newly established before the main negotiation to quickly register anticancer drugs without alternative drugs and treatments for severe and rare diseases. Accordingly, the negotiation period for the drug will be reduced from 60 days to 30 days. The NHIS announced on the 30th some revisions to the drug price negotiation guidelines containing such information.

According to the amendment, among PE drugs, drugs that are evaluated as RSA (Expenditure Cap drugs or Refund) will have a negotiation period of 30 days. These drugs, etc. can be consulted in advance before the main negotiation if ordered by the Minister of Health and Welfare. Accordingly, the target drugs may undergo prior co